Croma submits toxin for EU approval
Pharmaceutical company Croma Pharma has submitted its botulinum toxin drug file to the German Federal Institute for Drugs and Medical Devices (BfArM), for approval for the treatment of glabellar lines in the EU.
Pharmaceutical company Croma Pharma has submitted its botulinum toxin drug file to the German Federal Institute for Drugs and Medical Devices (BfArM), for approval for the treatment of glabellar lines in the EU.
A survey has indicated that only 22.5% of practitioners follow the recommended protocol for treating headaches with botulinum toxin.
An Instagram influencer has been accused of offering dermal fillers to an undercover reporter during COVID-19 lockdown.
Global biopharmaceutical company AbbVie has completed its acquisition of Allergan plc following regulatory approval of all government authorities.
The London Academy of Aesthetic Medicine has launched The Online Ultimate Toxin Course.
An Enforcement Notice on January 31 highlighting the rules and concerns around botulinum toxin advertising and other prescription-only medicines on social media has prompted a surge of enquiries to the Advertising Standards Authority (ASA).
Details of the Enforcement Notice relevant to all aesthetic clinics offering prescription-only medicines
Subscriber content
To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.
Already a subscriber? Log in
Medical aesthetic practitioners have raised safety and regulation concerns after ex-Love Island star and personal trainer Rykard Jenkins posted images on Instagram of himself training to administer botulinum toxin.
Following positive phase 2 results from its ready-to-use liquid formulation botulinum toxin, global pharmaceutical company Galderma has received a manufacturing license from the Swedish Medical Products Agency (MPA) for a new state-of-the-art manufacturing facility at the Center of Excellence, located in Uppsala, Sweden.
A pilot study of 18 male patients has demonstrated an increase in hair density and thickness following botulinum toxin treatment.